Cleared Traditional

K843281 - ACCUSCREEN TSH

K843281 is the FDA 510(k) clearance for ACCUSCREEN TSH by Neometrics, Inc.. It is a Class 2 Chemistry device (product code JLW) cleared through the Traditional 510(k) pathway after a 37-day FDA review.

K843281 · Neometrics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
37d
Days
Class 2
Risk

K843281 is an FDA 510(k) clearance for the ACCUSCREEN TSH. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Neometrics, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 26, 1984 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Neometrics, Inc. devices

Submission Details

510(k) Number K843281 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 1984
Decision Date September 26, 1984
Days to Decision 37 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 88d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 115
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K843281.
TERUMO SENSIBEAD EIA TSH KIT
K850376 · Terumo Medical Corp. · Mar 1985
ABBOTT HTSH EIA DIAGNOSTIC KIT
K843540 · Abbott Laboratories · Nov 1984
ENCORE TSH REAGENT
K843395 · Hybritech, Inc. · Oct 1984
AMERLEX-M TSH RIA
K842948 · Amersham Corp. · Sep 1984
BLOOD SPOT NEONATAL TSH RADIOIMMUNO
K841606 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1984
TANDEM-E THYROID STIMULATING HORMONE KIT
K832813 · Hybritech, Inc. · Oct 1983